Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Molecular Method Detects Colon Cancer Earlier

By LabMedica International staff writers
Posted on 24 Sep 2013
Techniques that identify gene variations that have been linked to colon cancer, may soon allow doctors to diagnose the disease in the very first stages, potentially saving patients' lives.

There is a need to provide those people who refuse screening colonoscopy with highly sensitive alternative tests, but the main problems in the attempt to establish molecular assays for noninvasive detection of early cancer stages or even of cancer precursors, are the choice of the appropriate biomarkers.

Scientists at the University of Potsdam (Germany) analyzed 80 human colon tissue and 31 associated feces specimens from subjects that had undergone routine colonoscopy and histopathologic assessment. More...
They used a combination of two techniques to analyze genetic variations within the cancerous and precancerous human colon tissue samples. One technique was the Locked Nucleic Acid (LNA)-based, wild-type blocking (WTB) polymerase chain reaction (PCR), which suppressed normal DNA present in large quantities, and the other was the High-Resolution Melting (HRM), which enhanced the detection of genetic variations. The WTB-PCR was conducted on an Eppendorf Mastercycler gradient (Hamburg, Germany) and the LC 480 Gene Scanning Software (Roche Diagnostics; Mannheim, Germany) was applied for HRM analysis.

There were two genes that were most frequently mutated in patients with colorectal cancer: a mutated Adenomatous polyposis coli (APC) gene was found in 60% of the patients and 40% of the patients has a mutated Kirsten rat sarcoma viral oncogene homolog (KRAS) gene. The two methods detected APC variations in 41 of the 80 samples and identified previously unknown variations in APC. The currently used direct sequencing technique only detected variations in 28 of the samples. When the scientists then analyzed 22 stool samples from patients with APC variations in their colon tissues and 9 control stool samples without APC variations, they successfully detected APC variations in 21 out of the 22 samples.

Bettina Scholtka, PhD, an assistant professor at the University of Potsdam and senior author of the study, said, “Tumor cells are released into stool from the surface of precancers and early-stage colon cancers, but detecting a cancer-initiating genetic mutation among a large quantity of normal DNA from a patient's stool is like looking for a needle in a haystack. By using our technique for examining a selection of genes that become mutated during the process of colon cancer formation, it is possible to detect the very first stage of colon cancer and even precancers in a stool sample.” The study was published in the September 2013 issue of the journal Cancer Prevention Research.

Related Links:
University of Potsdam
Eppendorf
Roche Diagnostics



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Automated Urinalysis Solution
UN-9000
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: (a) CTC separation using contraction-expansion inertial microfluidics. (b) CTC detection using the YOLOv8 deep learning model. (Image Credit: Junyi Ouyang, Haiqin Li)

Label-Free Platform Combines Microfluidics and AI for Circulating Tumor Cell Analysis

Liquid biopsy relies on detecting rare tumor-derived material in blood, but circulating tumor cells (CTCs) are especially difficult to capture because they are vastly outnumbered by normal blood cells.... Read more

Microbiology

view channel
Image Credit: 123RF

FDA-Cleared Multiplex PCR Test Detects 13 Respiratory Pathogens in a Single Sample

Respiratory tract infections can be difficult to distinguish at presentation because many cause overlapping, nonspecific symptoms and are initially grouped as influenza-like illnesses. Causes span a range... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.